Dan Leonard Analyst PerformanceManaging Director, Research Analyst at Royal Bank Of CanadaDan Leonard is a stock analyst at Royal Bank Of Canada in the healthcare sector, covering 33 publicly traded companies. Over the past year, Dan Leonard has issued 70 stock ratings, including buy and hold recommendations. While full access to Dan Leonard's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Leonard's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings147 Last 10 YearsBuy Recommendations62.07% 90 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution145RatingsDistribution of strong buy, buy, hold, and sell ratings by Dan Leonard.RatingPercentageCount Strong Buy0.0%0 ratings Buy62.1%90 ratings Hold37.2%54 ratings Sell0.7%1 ratingsOut of 145 total stock ratings issued by Dan Leonard at Royal Bank Of Canada, the majority (62.1%) have been Buy recommendations, followed by 37.2% Hold and 0.7% Sell.Best & Worst CallsBest Call000.0%GHMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CDNAApr 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ51.5% of companies on NASDAQ17 companiesNYSE48.5% of companies on NYSE16 companiesDan Leonard, an analyst at Royal Bank Of Canada, currently covers 33 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare33 companies100.0%Dan Leonard of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES18 companies54.5%BIOTECHNOLOGY7 companies21.2%HEALTHCARE PROVIDERS & SERVICES3 companies9.1%HEALTHCARE EQUIPMENT & SUPPLIES3 companies9.1%HEALTHCARE TECHNOLOGY1 company3.0%MEDICAL LABORATORIES1 company3.0% Dan Leonard's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGRALGRAIL9/17/2026Initiated Coverage$75.11$84.00Sector Perform$0.0000.00% ROIGRALGRAIL9/17/2026Upgrade$79.95Hold$0.0000.00% ROIQGENQiagen9/9/2026Initiated Coverage$42.37$47.00Neutral$0.0000.00% ROITXG10x Genomics9/9/2026Initiated Coverage$64.82$68.00Neutral$0.0000.00% ROIRGENRepligen9/9/2026Boost Price Target$166.99$225.00Buy$0.0000.00% ROIGHGuardant Health9/9/2026Boost Price Target$165.93$225.00Buy$0.0000.00% ROIAVTRAvantor9/9/2026Initiated Coverage$15.28$16.00Neutral$0.0000.00% ROIBRKRBruker9/9/2026Initiated Coverage$58.37$65.00Neutral$0.0000.00% ROISTVNStevanato Group9/9/2026Initiated Coverage$20.32$23.00Neutral$0.0000.00% ROINTRANatera9/8/2026Upgrade$328.18Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RVTYRevvity9/1/2026Initiated Coverage$128.76$135.00Sector Perform$0.0000.00% ROITXG10x Genomics9/1/2026Initiated Coverage$62.45$70.00Sector Perform$0.0000.00% ROIMTDMettler-Toledo International9/1/2026Initiated Coverage$1,405.98$1,515.00Sector Perform$0.0000.00% ROIRVTYRevvity9/1/2026Initiated Coverage$126.59$135.00Sector Perform$0.0000.00% ROITXG10x Genomics9/1/2026Initiated Coverage$59.98$70.00Sector Perform$0.0000.00% ROIAAgilent Technologies8/27/2026Boost Price Target$157.80$185.00Outperform$0.0000.00% ROINTRANatera8/7/2026Boost Price Target$315.56$350.00Outperform$0.0000.00% ROIWATWaters8/5/2026Boost Price Target$395.56$475.00Outperform$0.0000.00% ROIBIOBio-Rad Laboratories8/5/2026Boost Price Target$342.65$370.00Outperform$0.0000.00% ROIGHGuardant Health7/31/2026Boost Price Target$161.70$200.00Outperform$0.0000.00% ROIILMNIllumina7/31/2026Boost Price Target$199.17$230.00Outperform$0.0000.00% ROIGHGuardant Health7/31/2026Set Price Target$161.42$210.00$0.0000.00% ROIAVTRAvantor7/30/2026Boost Price Target$13.94$14.00Sector Perform$0.0000.00% ROITMOThermo Fisher Scientific7/24/2026Boost Price Target$564.63$580.00Sector Perform$0.0000.00% ROIDHRDanaher7/22/2026Boost Price Target$179.01$215.00Outperform$0.0000.00% ROITECHBio-Techne7/9/2026Downgrade$70.96$73.00Sector Perform$0.0000.00% ROIWATWaters7/8/2026Initiated Coverage$369.45$435.00Outperform$0.0000.00% ROIWATWaters7/8/2026Upgrade$377.42Moderate Buy$0.0000.00% ROIBRKRBruker6/24/2026Set Price Target$55.11$60.00$0.0000.00% ROIGHGuardant Health6/11/2026Initiated Coverage$130.90$185.00Outperform$0.0000.00% ROINTRANatera6/11/2026Initiated Coverage$219.23$275.00Outperform$0.0000.00% ROIGHGuardant Health6/11/2026Initiated Coverage$131.62$185.00Outperform$0.0000.00% ROIAAgilent Technologies5/27/2026Initiated Coverage$115.30$153.00Outperform$0.0000.00% ROIBIOBio-Rad Laboratories5/15/2026Initiated Coverage$244.93$320.00Outperform$0.0000.00% ROIAVTRAvantor5/14/2026Initiated Coverage$7.93$9.00Sector Perform$0.0000.00% ROIILMNIllumina5/14/2026Initiated Coverage$143.24$170.00Outperform$0.0000.00% ROIDHRDanaher5/14/2026Initiated Coverage$164.59$200.00Outperform$0.0000.00% ROITECHBio-Techne5/14/2026Set Price Target$44.74$62.00Outperform$0.0000.00% ROIRGENRepligen5/14/2026Initiated Coverage$103.38$160.00Outperform$0.0000.00% ROIAVTRAvantor5/14/2026Upgrade$7.64Hold$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayBIOBio-Rad Laboratories5/14/2026Upgrade$247.66Moderate Buy$0.0000.00% ROIDHRDanaher5/14/2026Upgrade$161.95Moderate Buy$0.0000.00% ROIILMNIllumina5/14/2026Upgrade$142.54Moderate Buy$0.0000.00% ROIRGENRepligen5/14/2026Upgrade$102.87Moderate Buy$0.0000.00% ROITECHBio-Techne5/14/2026Upgrade$43.30Moderate Buy$0.0000.00% ROIBRKRBruker5/7/2026Boost Price Target$42.30$45.00Neutral$0.0000.00% ROIDHRDanaher4/22/2026Lower Price Target$184.11$250.00Buy$0.0000.00% ROIAAgilent Technologies2/26/2026Lower Price Target$118.76$165.00Buy$0.0000.00% ROIRGENRepligen2/25/2026Lower Price Target$131.74$195.00Buy$0.0000.00% ROICRLCharles River Laboratories International2/25/2026Boost Price Target$168.32$175.00Neutral$0.0000.00% ROITXG10x Genomics2/20/2026Boost Price Target$19.19$20.00Neutral$0.0000.00% ROIBRKRBruker2/13/2026Reiterated Rating$37.09$49.00Neutral$0.0000.00% ROIAVTRAvantor2/12/2026Reiterated Rating$9.42$10.50Neutral$0.0000.00% ROIWATWaters2/10/2026Lower Price Target$329.29$370.00Neutral$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$184.48$240.00Buy$0.0000.00% ROITECHBio-Techne2/5/2026Reiterated Rating$68.67$79.00Buy$0.0000.00% ROITMOThermo Fisher Scientific1/30/2026Reiterated Rating$579.46$615.00Neutral$0.0000.00% ROIGHGuardant Health1/30/2026Reiterated Rating$111.21$175.00Buy$0.0000.00% ROIRGENRepligen1/16/2026Boost Price Target$161.69$200.00Buy$0.0000.00% ROIIQVIQVIA1/8/2026Boost Price Target$244.33$280.00Buy$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$159.11$180.00Buy$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$14.70$14.00Neutral$0.0000.00% ROITECHBio-Techne11/6/2025Boost Price Target$57.48$70.00Buy$0.0000.00% ROIBRKRBruker11/4/2025Boost Price Target$38.71$43.00Neutral$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$94.58$110.00Buy$0.0000.00% ROIIQVIQVIA10/29/2025Boost Price Target$219.01$250.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services10/24/2025Boost Price Target$307.07$355.00Buy$0.0000.00% ROITMOThermo Fisher Scientific10/23/2025Boost Price Target$568.42$590.00Neutral$0.0000.00% ROIAAgilent Technologies10/8/2025Upgrade$138.56$170.00Buy$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$62.55$80.00Buy$0.0000.00% ROITXG10x Genomics8/8/2025Boost Price Target$12.07$13.00Neutral$00.0000.00% ROIEXASExact Sciences8/7/2025Lower Price Target$41.32$53.00Neutral$0.0000.00% ROICERTCertara8/7/2025Lower Price Target$11.31$15.00Buy$0.0000.00% ROIMEDPMedpace7/29/2025Downgrade$453.05$305.00Sell$000.0000.00% ROITMOThermo Fisher Scientific7/24/2025Boost Price Target$478.05$500.00Neutral$000.0000.00% ROIDHRDanaher7/23/2025Lower Price Target$198.05$225.00Buy$000.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$194.46$225.00Buy$000.0000.00% ROITMOThermo Fisher Scientific7/8/2025Downgrade$426.65$460.00Neutral$000.0000.00% ROIMTDMettler-Toledo International5/20/2025Upgrade$1,159.20$1,350.00Buy$0000.0000.00% ROITXG10x Genomics5/13/2025Lower Price Target$9.68$12.00Neutral$00.0000.00% ROITECHBio-Techne5/9/2025Lower Price Target$49.98$70.00Buy$00.0000.00% ROIIQVIQVIA5/7/2025Lower Price Target$149.18$185.00Buy$000.0000.00% ROIBIOBio-Rad Laboratories5/2/2025Lower Price Target$236.83$310.00Buy$000.0000.00% ROIRVTYRevvity5/1/2025Upgrade$93.34$115.00Buy$00.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.50$70.00Buy$00.0000.00% ROITMOThermo Fisher Scientific4/24/2025Lower Price Target$421.04$500.00Buy$000.0000.00% ROIDHRDanaher4/23/2025Lower Price Target$203.97$240.00Buy$000.0000.00% ROIIQVIQVIA2/7/2025Lower Price Target$208.92$255.00Buy$000.0000.00% ROIAVTRAvantor1/17/2025Reiterated Rating$22.60$25.00Neutral$00.0000.00% ROICRLCharles River Laboratories International1/17/2025Reiterated Rating$165.60$185.00Neutral$000.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
